- US12303724utility2025Non-adult Human Dosing of Anti-cd30 Antibody-drug Conjugates for Treatment of Hematological or Lymphoid Cancer0 cites
- US12295940utility2025Viral Inhibitors, the Synthesis Thereof, and Intermediates Thereto0 cites
- US12295941utility2025Viral Inhibitors, the Synthesis Thereof, and Intermediates Thereto0 cites
- US12298319utility2025Method for Measuring Alpha Value of Muscarinic M1 Receptor Positive Allosteric Modulators0 cites
- USD1073933design2025Particle Prevention Adapter0 cites
- US12290531utility2025Compositions Targeting BCMA and Methods of Use Thereof0 cites
- US12291556utility2025Parathyroid Hormone Variants0 cites
- US12286400utility2025Isofagomine Salts, Methods of Use and Formulations0 cites
- US12286479utility2025Treatment with Anti-α4β7 Antibody0 cites
- US12281073utility2025Substituted Piperidine Compound and Use Thereof0 cites
- US12257277utility2025Adeno-associated Virus Formulations0 cites
- US12258540utility2025Environmentally Compatible Detergents for Inactivation of Lipid-enveloped Viruses0 cites
- US12246047utility2025Adeno-associated Virus Purification Methods0 cites
- US12239609utility2025Modular Vial Adapter0 cites
- US12240918utility2025Bispecific Antibodies Against Plasma Kallikrein and Factor XII0 cites
- US12241814utility2025Syringe Screening Device0 cites
- US12221441utility2025Plasma Kallikrein Inhibitors and Uses Thereof0 cites
- US12221453utility2025Substituted Pyrazolo[5′,1′:2,3]pyrimido[5,4-b][1,4]oxazines as TYK2 Inhibitors0 cites
- US12221460utility2025Antibody Drug Conjugates0 cites